about
Update on Hepatitis B Virus Infection: Focus on TreatmentHepatitis B virus treatment beyond the guidelines: special populations and consideration of treatment withdrawalCurrent and future antiviral drug therapies of hepatitis B chronic infectionAsian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.Peg-Interferon Lambda Treatment Induces Robust Innate and Adaptive Immunity in Chronic Hepatitis B Patients.Sulfamoylbenzamide derivatives inhibit the assembly of hepatitis B virus nucleocapsids.Dried blood spot sampling for hepatitis B virus serology and molecular testingThe changes of liver stiffness and its associated factors for chronic hepatitis B patients with entecavir therapyAntiviral therapies and prospects for a cure of chronic hepatitis B.Combination versus sequential monotherapy in chronic HBV infection: a mathematical approach.The role of HBsAg quantification for monitoring natural history and treatment outcome.HBsAg quantification: useful for monitoring natural history and treatment outcome.HBeAg-positive chronic hepatitis B: why do I treat my patients with pegylated interferon?Peginterferon α in the treatment of chronic hepatitis B.Genetic variation in STAT4 predicts response to interferon-α therapy for hepatitis B e antigen-positive chronic hepatitis B.Toward a Cure for Hepatitis B Virus Infection: Combination Therapy Involving Viral Suppression and Immune Modulation and Long-term Outcome.Hepatocyte targeting using pegylated asialofetuin-conjugated liposomes.Global strategies are required to cure and eliminate HBV infection.Asymmetric Modification of Hepatitis B Virus (HBV) Genomes by an Endogenous Cytidine Deaminase inside HBV Cores Informs a Model of Reverse Transcription.Interplay between hepatitis B virus and innate immune signaling pathways
P2860
Q26781990-6448C1A8-4490-438E-B3E9-722F71A058BEQ26995814-151A2610-072A-4546-848C-D18E2E02F15EQ28084820-8A50650B-14E7-4C79-A569-0B38CCA39E19Q30391932-4CB62A18-1908-4642-A6F4-3791B8E69FB2Q33734554-1F627D2B-7A2A-41EF-9DC7-D32F99F99D83Q34663350-2D13C8CF-5880-422E-8CCA-584AFFBCA314Q34684010-90399E38-61E6-4484-B187-4F1A5F00503AQ35135141-8539532D-4B18-489F-9E85-CCE28B356371Q35245231-FB68DCEE-E191-4557-BF42-D3FAEB8857C3Q35422530-9F96A6B0-8942-45EA-BC0D-1A2563A8F9E6Q38071397-CC8F0A05-9CF5-4C22-9B59-4CA127106BCEQ38174257-AAC8F535-FAB0-4D52-9140-00C4F09B09FDQ38174259-9C8B322F-7FC8-42DD-95F7-EA16B667378BQ38205028-A8265893-F41E-4DAE-BED2-D1A6678029C7Q40857335-BBDC893C-9C60-4C18-8B52-BCD8430D40F1Q45324582-89E89836-5BF1-41F2-9161-72CABF97C4C2Q45352781-D50012E2-65F0-4762-B896-752F58A817C9Q48860247-4ADEE0EB-359B-4305-BBF5-6651DED24EDBQ54264672-BBA21260-CDD1-46FB-96F2-87AA3C146CDBQ57207207-B4640B92-6583-4C96-A3E0-D648C1940FBD
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
New perspectives in the therapy of chronic hepatitis B.
@en
type
label
New perspectives in the therapy of chronic hepatitis B.
@en
prefLabel
New perspectives in the therapy of chronic hepatitis B.
@en
P1433
P1476
New perspectives in the therapy of chronic hepatitis B.
@en
P2093
Pietro Lampertico
P304
P356
10.1136/GUTJNL-2012-302085
P407
P478
61 Suppl 1
P50
P577
2012-05-01T00:00:00Z